Inhibitors of hemeprotein-catalyzed lipid peroxidation
US9133212B1 · kind B1 · utility
1Cited by
20References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 2013 |
| Grant date | Sep 15, 2015 |
| Priority date | — |
| Expiry date | May 7, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compounds for the treatment or prevention of oxidative damage in a mammalian subject. The treatment and/or prevention may be on inhibiting heme-induced lipid peroxidation. Also discloses are methods and compounds for treating or preventing isoprostane-mediated tissue damage.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.